PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 1997Head & Neck138 citationsOpen Access

Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer

View Full Paper
FDFrederic W.-B. DeleyiannisEWErnest A. WeymullerMCMarc D. Coltrera

Key Points

Key points are not available for this paper at this time.

Abstract

BACKGROUND: This study assessed the quality of life (QOL) of patients with advanced oropharyngeal cancer (stage III or IV) who were disease-free at 1 year posttreatment. METHODS: Between 1993 and 1994, 13 consecutive cases were identified from the University of Washington QOL registry. Patients were divided into two groups, depending on treatment: surgical group, 6 patients treated with surgical resection and postoperative radiotherapy; and nonsurgical group, 7 patients treated with definitive radiotherapy. RESULTS: Composite pretreatment and posttreatment QOL scores were similar for the two treatment groups. Subset analysis of QOL domains revealed that both treatment groups generally reported a worsening of chewing and swallowing. A worsening of appearance and of speech was more frequently reported by the surgical group. Sixty-seven percent of the surgically treated patients reported pain relief, as opposed to only 29% of the nonsurgical group. CONCLUSION: Composite QOL-score sensitivity may be compromised by inverse changes in individual QOL domains. Treatment-specific QOL domains may be more sensitive measures of outcome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Deleyiannis et al. (1997) studied this question.

synapsesocial.com/papers/6a21adbbcdf8429e7e5fed2fhttps://doi.org/10.1002/(sici)1097-0347(199709)19:6<466::aid-hed2>3.0.co;2-x
Ask AI
Helpful
Bookmark
Share
View Full Paper